Boosting mRNA‐Engineered Monocytes via Prodrug‐Like Microspheres for Bone Microenvironment Multi‐Phase Remodeling
Yuansheng Wu,Yingjie Zhu,Jie Chen,Lili Song,Chunping Wang,Yanglin Wu,Yanyang Chen,Jiancheng Zheng,Yuankun Zhai,Xiang Zhou,Youwen Liu,Yawei Du,Wenguo Cui
DOI: https://doi.org/10.1002/adhm.202403212
IF: 10
2024-11-08
Advanced Healthcare Materials
Abstract:After the in situ injection, the IL4 mRNA‐LNPs efficiently targeted monocytes for initial mRNA‐engineering during acute phase, promoting rapid inflammation reversal. Then, icariin will be sustainably released from prodrug‐like microspheres to boost the mRNA‐engineered monocytes to inhibit the fusion and osteoclast differentiation during repair phase. This multi‐phase regulation can effectively remodel the bone microenvironment. Monocytes, as progenitors of macrophages and osteoclasts, play critical roles in various stages of bone repair, necessitating phase‐specific regulatory mechanisms. Here, icariin (ICA) prodrug‐like microspheres (ICA@GM) are developed, as lipid nanoparticle (LNP) transfection boosters, to construct mRNA‐engineered monocytes for remodeling the bone microenvironment across multiple stages, including the acute inflammatory and repair phases. Initially, ICA@GM is prepared from ICA‐conjugated gelatin methacryloyl via a microfluidics system. Then, monocyte‐targeting IL‐4 mRNA‐LNPs are then prepared and integrated into injectable microspheres (mRNA‐ICA@GM) via electrostatic and hydrogen bond interactions. After bone‐defect injection, LNPs are controlled released from mRNA‐ICA@GM within 3 days, rapidly transfecting monocytes for monocyte IL‐4 mRNA‐engineering, which effectively suppressed acute inflammatory responses via polarization programming and paracrine signaling. Afterwards, ICA is sustainably released as well via cleavable boronate esters across multiple stages, cooperatively boosting the mRNA‐engineered monocytes to inhibit coenocytic fusion and osteoclastic function. Both in vitro and in vivo data indicated that mRNA‐ICA@GM can not only reverse the inflammatory environment but also suppress monocyte‐derived osteoclast formation to accelerate bone repair. In summary, mRNA‐engineered monocytes and ICA prodrug‐like microspheres are combined to achieve long‐lasting multi‐stage bone microenvironment regulation, offering a promising repair strategy.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials